[跳到内容]

临床试验 for Cancer 治疗

癌症类型首席研究员关键字或
临床试验.Gov ID
 

You searched for Category (乳房): 8 试验发现.

点击 排序 in the column header to 排序 records.
研究题目PI
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in 病人 who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early 乳腺癌 with an Increased Risk of Recurrence
阅读更多
山姆·本杰明,医学博士
A011801 - THE COMPASSHER2 TRIALS (COMPREHENSIVE USE OF PATHOLOGIC RESPONSE ASSESSMENT TO OPTIMIZE THERAPY IN HER2-POSITIVE BREAST CANCER): COMPASSHER2 RESIDUAL DISEASE (RD), 一个双盲, PHASE III RANDOMIZED TRIAL OF T-DM1 AND PLACEBO COMPARED WITH T-DM1 AND TUCATINIB
阅读更多
山姆·本杰明,医学博士
AFT-65: ASCENT-05: A Randomized, 非盲, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus 治疗 of Physician’s Choice in 病人 With Triple Negative 乳腺癌 Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy
阅读更多
山姆·本杰明,医学博士
CCTG马.39 - TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 乳腺癌
阅读更多
安娜·夏皮罗,医学博士
Intra-Operative 放射治疗 (IORT) 注册表 and Quality of Life Survey in Early Stage 乳腺癌
阅读更多
安娜·夏皮罗,医学博士
MammaPrint, 蓝图, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable 注册表 (FLEX)
阅读更多
山姆·本杰明,医学博士
Neurocognitive changes in breast cancer patients on hormonal therapy. Is there a difference between objective and perceived neurocognition?
阅读更多
山姆·本杰明,医学博士
NRG-BR007: A Phase III Clinical Trial Evaluating De-escalation Of 乳房 辐射 For Conservative 治疗 Of Stage I, 激素敏感, her2阴性, Oncotype Recurrence Score < 18 乳腺癌
阅读更多
安娜·夏皮罗,医学博士

再次搜索